Research Malaria Prevention Licensing Opportunity: mAbs That Target SporozoitesGlobal Biodefense StaffMarch 17, 2025
Research New Virus Characterization Center Will Conduct Sweeping Study of Human VirusesGlobal Biodefense StaffJanuary 23, 2025
Medical Countermeasures Lassa Fever Vaccine Study Supports Advancement to Phase I TrialGlobal Biodefense StaffAugust 14, 2024
Mosquitoes Capable of Carrying Zika Adapting for Northern Climates Biosurveillance January 28, 2016 …
Profectus BioSciences Initiates Ebola Vaccine Phase 1 Trial Medical Countermeasures January 20, 2016 …
NIAID Awards 5M for Non-Traditional Bacterial Infection Treatments Antimicrobial Resistance January 12, 2016 …